risedronic acid has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Degli Esposti, L | 1 |
| Perrone, V | 1 |
| Sangiorgi, D | 1 |
| Andretta, M | 1 |
| Bartolini, F | 1 |
| Cavaliere, A | 1 |
| Ciaccia, A | 1 |
| Dell'orco, S | 1 |
| Grego, S | 1 |
| Salzano, S | 1 |
| Ubertazzo, L | 1 |
| Vercellone, A | 1 |
| Gatti, D | 1 |
| Fassio, A | 1 |
| Viapiana, O | 1 |
| Rossini, M | 1 |
| Adami, G | 1 |
1 other study available for risedronic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes.
Topics: COVID-19; Diphosphonates; Humans; Retrospective Studies; Risedronic Acid; SARS-CoV-2 | 2021 |